Managing Botulinum Toxin A Dosing for Laryngeal Dystonia
LD patients who required high doses of BTX highlighted the differences in treatment among various LD subtypes and suggested that dose variability may occur in patients who do not respond to low-dose BTX. These results stress the importance of individualized treatment options for LD patients.
Authors
- Robert T. Sataloff (ORCID: https://orcid.org/0000-0001-5146-6319)
- Pelin Yüksel (ORCID: https://orcid.org/0009-0000-0297-363X)
- Katherine D. Mullen
- Kathryn A Mozzochi
Institutions
- SUNY Upstate Medical University (US)
- Drexel University (US)
- Philadelphia University (US)
Publication Details
- Journal
- Journal of Voice
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.jvoice.2025.09.025
- Citations
- 1
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39